BioWorld Asia

Oct. 6, 2010

One GIANT Step for Mankind: New Genes for Height Control

Agennix Nets $105M in Share Offer to Develop Talactoferrin

GW Testing Cannabinoids in Diabetes, Metabolic Syndrome

'Father of 4 Million' Wins Medicine Nobel for IVF Work

Other News To Note

Zealand's Lixisenatide Hits Mark in Phase III Combo Trial

Lixisenatide, the Type II diabetes molecule discovered by Zealand Pharma A/S, met the primary endpoint in the first Phase III combination trial. (BioWorld International) Read More

GlaxoSmithKline Spins Out Firm with Ion Channel Portfolio

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...